Product image of Idhifa (Enasidenib) 100mg Tablet supplied by GNH India

Idhifa

Active Ingredient:
Enasidenib
Form:
Tablet
Brand:
IDHIFA
Origin:
USA

Idhifa (Enasidenib Tablet) 100mg

IDHIFA (enasidenib) 100mg tablets are prescribed for certain types of acute myeloid leukemia (AML). This targeted therapy helps manage cancer by blocking specific mutations. Suitable for adults with relapsed or refractory AML. Store at 15-25°C in a dry place.

Strength

100mg

Pack Size

30s

Storage

15-25°

Manufacturer / TM Owner

Celgene

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • IDHIFA (enasidenib) 100mg tablets are used to treat adults with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. This targeted therapy works by inhibiting mutant IDH2 proteins to slow cancer progression. It is prescribed when standard treatments have not been effective. Patients should discuss suitability with their healthcare provider.

Side Effects

  • IDHIFA (enasidenib) 100mg tablets may help reduce disease symptoms and slow cancer progression in eligible patients. Common effects include gastrointestinal changes and fatigue. Some patients experience temporary improvements in blood cell counts. Individual responses vary based on medical history and treatment plan.

Precautions & Warnings

  • Keep IDHIFA (enasidenib) 100mg tablets in the original packaging to protect from moisture. Store at room temperature (15-25°C) and avoid exposure to heat or direct sunlight. Do not remove tablets from blister packs until ready to take. Keep out of reach of children and pets.

Avoid Interactions

  • IDHIFA (enasidenib) 100mg tablets may interact with other medications, including certain antibiotics and antifungals. Avoid grapefruit products as they can affect how the drug works. Discuss all current medications with a healthcare provider before starting treatment. Alcohol use should be limited or avoided during therapy.

Frequently Asked Questions

IDHIFA 100mg tablets are used to treat adults with relapsed or refractory acute myeloid leukemia (AML) that has a specific genetic mutation.

Store IDHIFA 100mg tablets at room temperature (15-25°C) in the original packaging to protect from moisture.

Consult your healthcare provider before taking IDHIFA with other medications, as interactions may occur with certain drugs.

IDHIFA is a targeted therapy, not a traditional chemotherapy, and works by blocking specific mutations in cancer cells.

Avoid grapefruit products and limit alcohol use while taking IDHIFA 100mg tablets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Enasidenib

Enasidenib 100mg

Enasidenib 100mg

100mg Tablet
Idhifa 50 mg

Idhifa 50 mg

50 MG Tablet
IDHIFA 100mg

IDHIFA 100mg

100mg Tablet

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT